Home > Collections > Topics in Regulatory Affairs for Pharmaceuticals
Topics in Regulatory Affairs for Pharmaceuticals
View PDF

Topics in Regulatory Affairs for Pharmaceuticals

Publisher: FX Conferences
  • Description

Stay current on the ever-changing regulatory environment with 10 audio recordings of industry experts offering practical guidance for executives, directors, managers, and associates concerned with regulations in the pharmaceutical market.

Ovid and FX Conferences offer thousands of professional development hours for your teams, conveniently packaged and delivered as a collection of audio recordings to save you time and money.

Topics in this collection have a global appeal and are relevant for multiple departments within your organization—R & D, Market Research, Compliance, and more. Each of the 10 recordings consists of a 45-minute, telephone-based presentation delivered by expert international speakers, followed by a 15-minute question-and-answer session (collection available with and without transcripts).

RECORDINGS:

1. Requests for Off-label Information – The FDA Guidance and Its Implications
Speakers: Wendy Blackburn, Executive Vice President, Intouch Solutions, and Dr. Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm

2. Preparing for Upcoming Changes in EU Pharmacovigilance Requirements
Speaker: Dr. Jan Petracek, CEO & Chief Consultant, PharmInvent

3. Industry Update – Europe's New Pharmacovigilance Regulations
Speaker: Stefan Blesse, Principal Consultant, Granzer Regulatory Consulting & Services

4. Effectively Managing an FDA Inspection – Opening Meeting to Rapid 483 Response
Speaker: John Avellanet, Managing Director & Principal, Cerulean Associates LLC

5. FDA Update – Responding to Unsolicited Requests for Off-Label Information
Speakers: Marian J. Lee, Partner, and Beverly H. Lorell, Senior Adviser, King & Spalding LLP

6. Centralized vs Onsite Monitoring – Applying FDA's Risk-based Approach
Speaker: Sandra Maddock, President & CEO, IMARC Research, Inc

7. Off-label Promotion – What FDA Looks For & What You Need to Know
Speaker: Alan Minsk, Partner, Arnall Golden Gregory LLP

8. Expedited and Periodic Safety Reporting for Drug Trials
Speakers: Helen Colquhoun, Vice President, Cromsource

9. Following the 510(k) and 505(b)(2) Pathways to Regulatory Approval
Speaker: Dr. Joy Frestedt. President & CEO, Frestedt Incorporate

10. Successfully Responding to FDA 483s and Warning Letters
Speaker: Michael A. Swit, Special Counsel, FDA Practice, Duane Morris LLP

Free Instant Access
This Month

JOTM
Ovid Emcare A premium nursing and allied health database ideal for practice, research, or education. Uncover evidence-based literature and the latest scientific advancements that support patient treatment and lead to more cost-effective and higher quality care.
JOTM
Maternity and Infant Care A key information resource used by maternity health care professionals and student midwives worldwide to support their research, practice, and study requirements.
JOTM
The American Journal of Nursing (AJN) Peer reviewed and evidence-based, AJN is the oldest and most honored broad-based nursing journal in the world. Considered the profession’s premier journal with numerous awards for excellence in editing and dissemination, including several award-winning series.
JOTM
Journal of Cardiovascular Nursing Official journal of the Preventive Cardiovascular Nurses Association, provides thorough coverage of timely topics and information that is extremely practical for daily, on-the-job use.

Noteworthy

Doody's Featured Books
Lippincott Manual of Nursing Practice, 11th Edition
A classic nursing reference, the fully updated 11th Edition, offers expert nursing knowledge and much-needed practical guidance on patient care.

Lippincott Visual Nursing: A Guide to Diseases, Skills, and Treatments, 3rd Edition
This colorful book for practicing nurses and nursing students provides a unique approach to learning important clinical concepts and techniques.